Thymectomy: Role in the treatment of myasthenia gravis

Journal of Neurology

Volumn 260, Issue 7, 2013, Pages 1798-1801

  Spillane, J ^a   Hayward, M ^b   Hirsch, N P ^c   Taylor, C ^c   Kullmann, D M ^a   Howard, R S ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Myasthenia gravis; Thymectomy; Thymoma

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID; PREDNISOLONE;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYASTHENIA GRAVIS; PATIENT SAFETY; PRIORITY JOURNAL; REMISSION; THYMECTOMY; THYMOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RETROSPECTIVE STUDIES; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 84880268868     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6880-8     Document Type: Article

References (15)

1. Blalock A, Mason MF, Morgan HJ et al (1939) Myasthenia gravis and tumors of the thymic region: report of a case in which the tumor was removed. Ann Surg 110(4):544-561
2. Masaoka A, Yamakawa Y, Niwa H et al (1996) Extended thymectomy for myasthenia gravis patients: a 20 year review. Ann Thorac Surg 62(3):853-859
3. Lanska DJ (1990) Indications for thymectomy in myasthenia gravis. Neurology 40(12):1828-1829
4. Newsom-Davis J, Cutter G, Wolfe GI et al (2008) Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone. Ann NY Acad Sci 1132:344-347
5. Gronseth GS, Barohn RJ (2002) Thymectomy for myasthenia gravis. Curr Treat Options Neurol. 4(3):203-209
6. O'Riordan JI, Miller DH, Mottershead JP et al (1998) Thymectomy: its role in the management of myasthenia gravis. Eur J Neurol 5:1-7
7. Jaretzki A, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 55(1):16-23
8. Takanami I, Abiko T, Koizumi S (2009) Therapeutic outcomes in thymectomied patients with myasthenia gravis. Ann Thorac Cardiovasc Surg. 15(6):373-377
9. Evoli A, Bianchi MR, Riso R et al (2008) Response to therapy in myasthenia gravis with anti-MuSK antibodies. Ann NY Acad Sci 1132:76-83
10. Papatestas AE, Genkins G, Kornfeld P, Eisenkraft JB, Fagerstrom RP, Pozner J et al (1987) Effects of thymectomy in myasthenia gravis. Ann Surg 206(1):79-88
11. Grob D, Arsura EL, Brunner NG, Namba T (1987) The course of myasthenia gravis and therapies affecting outcome. Ann NY Acad Sci 505:472-499
12. Scadding GK, Havard CW, Lange MJ, Domb I (1985) The long term experience of thymectomy for myasthenia gravis. J Neurol Neurosurg Psychiatr 48(5):401-406
13. Kattach H, Anastasiadis K, Cleuziou J, Buckley C, Shine B, Pillai R et al (2006) Transsternal thymectomy for myasthenia gravis: surgical outcome. Ann Thorac Surg 81(1):305-308
14. Bachmann K, Burkhardt D, Schreiter I, Kaifi J, Schurr P, Busch C et al (2009) Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement. Surgery 145(4):392-398
15. Gronseth GS, Barohn RJ (2000) Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55(1):7-15